LEP and breast cancer: The aim is to evaluate the blood levels of leptin and adiponectin between these two groups and to confirm the previously mentioned hypothesis: obese or overweight premenopausal women without breast cancer would have high levels of adiponectin and low levels of leptin despite a high BMI.